<?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName art560.dtd?>
<?SourceDTD.Version 5.6.0?>
<?ConverterInfo.XSLTName elsevier2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?origin publisher?>
<?FILEmeta_CSBJ955 xml ?>
<?FILEmain xml ?>
<?FILEmain pdf ?>
<?FILEgr1 jpg ?>
<?FILEgr2 jpg ?>
<?FILEgr3 jpg ?>
<?FILEga1 jpg ?>
<?FILEmmc1 docx ?>
<?FILEmmc2 csv ?>
<?properties open_access?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Comput Struct Biotechnol J</journal-id>
    <journal-id journal-id-type="iso-abbrev">Comput Struct Biotechnol J</journal-id>
    <journal-title-group>
      <journal-title>Computational and Structural Biotechnology Journal</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2001-0370</issn>
    <publisher>
      <publisher-name>Research Network of Computational and Structural Biotechnology</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8113760</article-id>
    <article-id pub-id-type="pii">S2001-0370(21)00139-2</article-id>
    <article-id pub-id-type="doi">10.1016/j.csbj.2021.04.027</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Data Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>AddictGene: An integrated knowledge base for differentially expressed genes associated with addictive substance</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="au005">
        <name>
          <surname>Shi</surname>
          <given-names>Leisheng</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="fn1" ref-type="fn">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au010">
        <name>
          <surname>Wang</surname>
          <given-names>Yan</given-names>
        </name>
        <email>wyan@psych.ac.cn</email>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="fn1" ref-type="fn">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au015">
        <name>
          <surname>Li</surname>
          <given-names>Chong</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au020">
        <name>
          <surname>Zhang</surname>
          <given-names>Kunlin</given-names>
        </name>
        <email>zhangkl@psych.ac.cn</email>
        <xref rid="af005" ref-type="aff">a</xref>
      </contrib>
      <contrib contrib-type="author" id="au025">
        <name>
          <surname>Du</surname>
          <given-names>Quansheng</given-names>
        </name>
        <email>duqs@nsfc.gov.cn</email>
        <xref rid="af015" ref-type="aff">c</xref>
      </contrib>
      <contrib contrib-type="author" id="au030">
        <name>
          <surname>Zhao</surname>
          <given-names>Mei</given-names>
        </name>
        <email>zhaomei@psych.ac.cn</email>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="cor1" ref-type="corresp">⁎</xref>
      </contrib>
      <aff id="af005"><label>a</label>CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China</aff>
      <aff id="af010"><label>b</label>University of Chinese Academy of Sciences, Beijing 101408, China</aff>
      <aff id="af015"><label>c</label>Department of Life Sciences, National Natural Science Foundation of China, Beijing 100085, China</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>⁎</label>Corresponding author at: CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China. <email>zhaomei@psych.ac.cn</email></corresp>
      <fn id="fn1">
        <label>1</label>
        <p id="np005">These authors contributed equally to this work.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="pmc-release">
      <day>19</day>
      <month>4</month>
      <year>2021</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>19</day>
      <month>4</month>
      <year>2021</year>
    </pub-date>
    <volume>19</volume>
    <fpage>2416</fpage>
    <lpage>2422</lpage>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>10</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>8</day>
        <month>4</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>9</day>
        <month>4</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2021 The Authors</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
      </license>
    </permissions>
    <abstract abstract-type="graphical" id="ab005">
      <title>Graphical abstract</title>
      <p>AddictGene and its easy-to-use web interface was built by integrating gene expression, gene-gene interaction, gene-drug interaction and epigenetic regulatory annotation of differentially expressed genes associated with abused substances. The common pathways and genes of multiple drugs irrespective of stages of addiction was identified.</p>
      <p>
        <fig id="f0020" position="anchor">
          <graphic xlink:href="ga1"/>
        </fig>
      </p>
    </abstract>
    <abstract id="ab010">
      <p>Addiction, a disorder of maladaptive brain plasticity, is associated with changes in numerous gene expressions. Nowadays, high-throughput sequencing data on addictive substance-induced gene expression have become widely available. A resource for comprehensive annotation of genes that show differential expression in response to commonly abused substances is necessary. So, we developed AddictGene by integrating gene expression, gene-gene interaction, gene-drug interaction and epigenetic regulatory annotation for over 70,156 items of differentially expressed genes associated with 7 commonly abused substances, including alcohol, nicotine, cocaine, morphine, heroin, methamphetamine, and amphetamine, across three species (human, mouse, rat). We also collected 1,141 addiction-related experimentally validated genes by techniques such as RT-PCR, northern blot and <italic>in situ</italic> hybridization. The easy-to-use web interface of AddictGene (<ext-link ext-link-type="uri" xlink:href="http://159.226.67.237/sun/addictgedb/" id="ir005"><underline>http://159.226.67.237/sun/addictgedb/</underline></ext-link>) allows users to search and browse multidimensional data on DEGs of their interest: 1) detailed gene-specific information extracted from the original studies; 2) basic information about the specific gene extracted from NCBI; 3) SNP associated with substance dependence and other psychiatry disorders; 4) expression alteration of specific gene in other psychiatric disorders; 5) expression patterns of interested gene across 31 primary and 54 secondary human tissues; 6) functional annotation of interested gene; 7) epigenetic regulators involved in the alteration of specific genes, including histone modifications and DNA methylation; 8) protein–protein interaction for functional linkage with interested gene; 9) drug-gene interaction for potential druggability. AddictGene offers a valuable repository for researchers to study the molecular mechanisms underlying addiction, and might provide valuable insights into potential therapies for drug abuse and relapse.</p>
    </abstract>
    <kwd-group id="kg005">
      <title>Keywords</title>
      <kwd>Drug dependence</kwd>
      <kwd>Gene expression</kwd>
      <kwd>Drug abuse</kwd>
      <kwd>Database</kwd>
      <kwd>Addiction</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec id="s0005">
    <label>1</label>
    <title>Introduction</title>
    <p id="p0005">Addiction, a chronic, relapsing brain disease, is characterized by loss of control over harmful substances intake and compulsive substance consumption despite serious adverse consequences <xref rid="b0005" ref-type="bibr">[1]</xref>. Alteration of gene expression has been linked to dependence, withdrawal, and relapse of addictive substance-dependent individuals in both animal and human studies <xref rid="b0010" ref-type="bibr">[2]</xref>, <xref rid="b0015" ref-type="bibr">[3]</xref>, <xref rid="b0020" ref-type="bibr">[4]</xref>. Earlier studies revealed numerous expression-altered genes related to addictive substance-dependence including immediate-early genes, transcription factors, and various neurotransmitter genes <xref rid="b0025" ref-type="bibr">[5]</xref>. For example, immediate-early genes include members of the Fos family (<italic>Fos</italic>, <italic>FosB</italic>), the Jun family (<italic>c-Jun, JunB,</italic> and <italic>JunD</italic>) and Zif268 (<italic>Egr1</italic>) overexpressed transiently or permanently in response to a wide range of addictive substances. Transcription factors (CREB, NF-κb) could exert a crucial role in addiction development by influencing the expression of numerous genes simultaneously <xref rid="b0010" ref-type="bibr">[2]</xref>. Additionally, receptors of dopamine and NMDA, neurotrophic factors, and genes involved in the circadian rhythm were also demonstrated to contribute to the development of addiction <xref rid="b0025" ref-type="bibr">[5]</xref>. Therefore, identifying the genes responding to addictive substance exposure and uncovering their regulators will not only improve the understanding of the mechanisms underlying addiction, but will also provide valuable insights into potential therapies for addiction and relapse.</p>
    <p id="p0010">Following the development of high-throughput transcriptome profiling technologies, gene expression data relating to changes induced by addictive substances have become widely available. However, a resource for comprehensive deciphering and annotation of genes that show differential expression in response to several commonly abused dependence substances is still lacking. To the best of our knowledge, one such database, ERGR database <xref rid="b0030" ref-type="bibr">[6]</xref>, was built for depositing genes related to just one kind of addictive substance, ethanol. It was developed nearly 10 years ago and hosts ethanol-related genes curated from multiple public data sets including linkage, association and microarray-based gene expression. During the preceding decade, gene expression data relating to the use of addictive substances have accumulated rapidly. Thus, there is a growing need to build a platform to collect and integrate the current multi-omic data from multiple studies for convenient retrieval by researchers and clinicians.</p>
    <p id="p0015">To fulfill this need, here, we have developed AddictGene (<ext-link ext-link-type="uri" xlink:href="http://159.226.67.237/sun/addictgedb/" id="ir010">http://159.226.67.237/sun/addictgedb/</ext-link>), which integrated gene expression, gene-gene interaction, gene-drug interaction and regulatory annotation for over 33,821 items of differentially expressed genes associated with 7 commonly abused substances across three species (human, mouse, rat) from 205 publications. The database presents an easy-to-use web interface that allows users to search, visualize and account for addiction-related genes. In addition, it provides researchers and clinicians substantial convenience to explore the underlying regulatory mechanism for alteration of specific addiction-related genes and drug-gene interaction for potential druggability.</p>
  </sec>
  <sec id="s0010">
    <label>2</label>
    <title>Methods and analysis:</title>
    <sec id="s0015">
      <label>2.1</label>
      <title>Data collection and curation</title>
      <p id="p0020">To create a list of DEGs (differentially expressed genes) relevant to addiction, a comprehensive search was performed for drug-related expression studies. We searched the PubMed database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nih.gov/pubmed" id="ir015"><underline>http://www.ncbi.nih.gov/pubmed</underline></ext-link>) with the following query terms: addiction [Title/Abstract] AND the name of a specific addictive substances such as heroin [Title/Abstract] OR Psychoactive substances[Title/Abstract] OR Drug[Title/Abstract] AND (addiction[Title/Abstract] OR dependence[Title/Abstract] OR abuse[title/Abstract] OR use[Title/Abstract]) AND gene [Title/Abstract] OR gene expression [Title/Abstract] OR PCR [Title/Abstract] OR RNA-seq [Title/Abstract] OR microarray [Title/Abstract] AND (associate* [Title/Abstract]). Consequently, more than 500 publications dating from 2000 to 2020 were obtained. Abstracts of these publications were manually screened on the basis of the following inclusion criteria: 1) original manuscript written in English; 2) gene expression studies conducted in humans or animal model related addiction; 3) DEGs identified by PCR, northern blot, <italic>in situ</italic> hybridization, microarray or RNA-seq; 4) unambiguous phenotype (e.g. addiction or dependence, craving, drug-seeking, withdrawal etc.) assessed on specific scales by trained interviewers, psychologists or researchers and drug usage is not limited to one kind of drug used concurrently; 5) results satisfying the significance threshold of <italic>p</italic>-value &lt; 0.05.</p>
      <p id="p0025">The full text of each eligible article was read carefully, and detailed information pertaining to each gene investigated in the study was extracted manually. For each gene described in a study, more detailed information was extracted regarding its fold change, <italic>p</italic>-value and/or adjusted <italic>p</italic>-value, tissue type, the experimental method employed, the drug administered, the model organism, the phenotype, and the publication. Consequently, the AddictGene database contains 70,156 items of dependence substances-associated DEGs corresponding to seven kinds of substances from three species and 341 eligible publications. From the literature, we collected 1,141 addiction-related genes, whose alterations were validated by techniques such as RT-PCR (Reverse transcription PCR), northern blot and <italic>in situ</italic> hybridization.</p>
    </sec>
    <sec id="s0020">
      <label>2.2</label>
      <title>Gene annotation and analysis</title>
      <p id="p0030">To provide an informative ‘gene card’ for each DEG relevant to addiction, its annotation was designed to include basic information, gene-related disease, tissue expression patterns, functional and regulatory annotation, protein–protein interaction and drug-gene interaction. We downloaded the gene annotation files from the NCBI's reference sequence (RefSeq) database (ftp://ftp.ncbi.nlm.nih.gov/refseq/) and extracted the annotation information for our database. For each gene, we retrieved basic information such as gene symbol, its aliases, and full name. Similarly, we extracted gene ontology (GO) and pathway annotations from the gene2go files downloaded from the GO website (<ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org/" id="ir020"><underline>http://www.geneontology.org/</underline></ext-link>) and BioSystems (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/biosystems" id="ir025"><underline>https://www.ncbi.nlm.nih.gov/biosystems</underline></ext-link>), respectively.</p>
      <p id="p0035">To facilitate a comprehensive understanding of identified DEGs, we downloaded gene expression data of other psychiatric disorders from Gene Expression Omnibus of NCBI (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/" id="ir030"><underline>https://www.ncbi.nlm.nih.gov/geo/</underline></ext-link>), and tissue expression pattern of each gene from Genotype-Tissue Expression (GTEx) (<ext-link ext-link-type="uri" xlink:href="http://www.gtexportal.org/" id="ir035">http://www.gtexportal.org/</ext-link>). In addition, we extracted information about potential drug targets to gene of interest and their protein–protein interaction network from DGIdb (<ext-link ext-link-type="uri" xlink:href="http://www.dgidb.org/" id="ir040">http://www.dgidb.org/</ext-link>) and InBio Map (<ext-link ext-link-type="uri" xlink:href="https://www.intomics.com/inbio/map.html" id="ir045">https://www.intomics.com/inbio/map.html</ext-link>), respectively. To provide insight into the relationship between certain gene and genetic vulnerability to other psychiatric and neurodegenerative disease, we integrated genome-wide association study (GWAS) data of other psychiatric disorders and neurodegenerative disease.</p>
    </sec>
    <sec id="s0025">
      <label>2.3</label>
      <title>Analysis of epigenomic regulation</title>
      <p id="p0040">To identify the potential epigenetic regulators involved in the expression of DEGs, we integrated epigenomic regulatory information into our current database. Literature-based methylation alterations of specific genes associated with drug dependent were retrieved from PubMed database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nih.gov/pubmed" id="ir050"><underline>http://www.ncbi.nih.gov/pubmed</underline></ext-link>), and methylation levels of specific gene’s promoter were also retrieved from MethBank (<ext-link ext-link-type="uri" xlink:href="http://bigd.big.ac.cn/methbank" id="ir055"><underline>http://bigd.big.ac.cn/methbank</underline></ext-link>). In addition, raw data of 180 embryonic chromatin immunoprecipitation sequencing (ChIP-seq) (<xref rid="s0080" ref-type="sec">Supplementary Table S1</xref>) datasets were downloaded from GEO of NCBI. After removing sequencing adapters and low-quality sequences, all ChIP-seq data were mapped to the hg38 genome for humans or mm10 genome for mouse using SpeedSeq (v0.1.2) <xref rid="b0035" ref-type="bibr">[7]</xref>. Then, the bigwig files for JBrowse visualization were generated from BAM files using ‘bamCoverage’ from deepTools <xref rid="b0040" ref-type="bibr">[8]</xref> with parameters ‘–ignoreDuplicates–normalizeUsingRPKM –skipNonCoveredRegions –binSize 25 –ignoreForNormalization chrX chrM’.</p>
    </sec>
    <sec id="s0030">
      <label>2.4</label>
      <title>Database construction and content organization</title>
      <p id="p0045">AddictGene was developed to have a user-friendly web interface supporting versatile browsing and search functionalities. All data were stored and managed in the MySQL relational database. The users may access the data or perform advanced search freely through the web interface (<ext-link ext-link-type="uri" xlink:href="http://159.226.67.237/sun/addictgedb/" id="ir060"><underline>http://159.226.67.237/sun/addictgedb/</underline></ext-link>). The flow charts detailing the search, screening and mining of eligible studies have been summarized in <xref rid="f0005" ref-type="fig">Fig. 1</xref>. After searching the literature comprehensively and careful screening, we obtained 205 eligible papers for further data extraction.<fig id="f0005"><label>Fig. 1</label><caption><p>The process of data collection and data analysis in AddictGene.</p></caption><graphic xlink:href="gr1"/></fig></p>
    </sec>
    <sec id="s0035">
      <label>2.5</label>
      <title>Database usage and access</title>
      <p id="p0050">AddictGene provides two approaches for searching the data. First, there is a quick search box on the homepage for conducting a search by entering gene symbols or the names of addictive substances. Second, AddictGene provides an advanced search page, on which users may combine different search terms (e.g. gene symbol, addictive substance, species, techniques, expression fold change and adjusted <italic>p-</italic>value) for a 5. more defined search. The search results page includes detailed information (e.g. addictive substance, species, techniques, treatment details, tissue/cell type, expression fold change, <italic>p</italic>-values) extracted from the original studies (<xref rid="f0010" ref-type="fig">Fig. 2</xref>).<fig id="f0010"><label>Fig. 2</label><caption><p>An overview of the connections of function modules for data access and upload in AddictGene.</p></caption><graphic xlink:href="gr2"/></fig></p>
      <p id="p0055">In addition, AddictGene provides researchers with a powerful search engine and a user-friendly interface to access different data types and links (<xref rid="f0010" ref-type="fig">Fig. 2</xref>). The search results consists of 9 categories: 1) detailed gene-specific information extracted from the original studies; 2) basic information about the specific gene extracted from NCBI; 3) SNP associated with substance dependence and other psychiatry disorders; 4) expression alteration of specific gene in other psychiatric disorders; 5) expression patterns of interested gene across 31 primary and 54 secondary human tissues; 6) functional annotation of interested gene; 7) two kinds of potential epigenetic regulators involved in the alteration of specific genes, including histone modifications and DNA methylation; 8) protein–protein interaction for functional linkage with interested gene; 9) drug-gene interaction for potential druggability. Thus, AddictGene provides a range of data query tools that users can employ to investigate the detailed annotation of the identified DEGs.</p>
    </sec>
  </sec>
  <sec id="s0040">
    <label>3</label>
    <title>Results</title>
    <sec id="s0045">
      <label>3.1</label>
      <title>Data integration and analyses</title>
      <p id="p0060">It is suggested that common biological mechanisms underlie addiction to many harmful substances since they all cause certain shared effects upon acute or chronic exposure. In the current study, based on our curated data, we defined the orthologous DEGs of the three species shared by multiple dependence substances as “common genes”. Upon analyzing data from chronic substance treatment and recovery programs or person with substance use disorder, we found that 61 DEGs were shared by at least four kinds of substances (<xref rid="f0015" ref-type="fig">Fig. 3</xref>A). On analyzing data of acute drug treatment, we found that 32 DEGs were shared by at least two kinds of drugs. On analyzing drug withdrawal data, we found that 46 DEGs were shared by at least two kinds of drugs. Pathway analysis of DEGs responding to different drug treatment was performed and top10 was as listed (<xref rid="t0005" ref-type="table">Table 1</xref>). DEG responding to chronic drug treatment were enriched in harmful substances addiction related pathways, cAMP, MAPK, neurotrophin, oxytocin, and GnRH signaling pathways. DEGs responding to acute drug treatment were enriched in amphetamine addiction and immune related pathways such as TNF and IL-17 signaling pathway. And DEGs responding to drug withdrawal were enriched in Estrogen, Ras, Toll-like receptor, JAK-STAT, ErbB signaling pathway, and Nervous system pathways such as Huntington disease, Cholinergic synapse, Long-term potentiation and <italic>et al</italic>. Besides we did pathway enrichment analyses of DEGs shared by multiple drugs. The top ten enriched pathways mainly are Substance dependence pathways and Nervous system pathways (<xref rid="f0015" ref-type="fig">Fig. 3</xref>B). Protein-protein interaction networks of common genes revealed several well-recognized addiction-associated genes including <italic>FOS</italic>, <italic>JUN</italic>, <italic>EGR1</italic> and <italic>BDNF</italic> play crucial role in addiction-related behaviors (<xref rid="f0015" ref-type="fig">Fig. 3</xref>C).<fig id="f0015"><label>Fig. 3</label><caption><p>Pathway enrichment and overlapping gene analysis. (A) Number of overlapping genes responding to different harmful substances. (B) Top 10 enriched pathways of ’common’ differentially expressed genes. (C) Protein-protein interaction network of ’common’ differentially expressed genes. Disease (D) and drug (E) information related to gene <italic>CARTPT</italic>. (F) Histone H3K4me3 modification sites around <italic>CARTPT</italic> during embryonic development process.</p></caption><graphic xlink:href="gr3"/></fig><table-wrap position="float" id="t0005"><label>Table 1</label><caption><p>Top 10 pathways of DEGs responding to different drug treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Type of drug treatment</th><th>Pathway</th></tr></thead><tbody><tr><td>Acute drug treatment</td><td>Amphetamine addiction, Apoptosis, MAPK signaling pathway, FoxO signaling pathway, IL-17 signaling pathway, TNF signaling pathway, cAMP signaling pathway, Cocaine addiction, Protein processing in endoplasmic reticulum, Leishmaniasis</td></tr><tr><td>Chronic drug treatment</td><td>Relaxin signaling pathway, Calcium signaling pathway, Dopaminergic synapse, Neurotrophin signaling pathway, Amphetamine addiction, Oxytocin signaling pathway, Cholinergic synapse, cAMP signaling pathway, Cocaine addiction, GnRH signaling pathway</td></tr><tr><td>Drug withdrawal</td><td>Nicotine addiction, MAPK signaling pathway, Long-term depression, Huntington disease, Estrogen signaling pathway, Ras signaling pathway, Toll-like receptor signaling pathway, JAK-STAT signaling pathway, ErbB signaling pathway, Cholinergic synapse</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="s0050">
      <label>3.2</label>
      <title>Examples of implication</title>
      <p id="p0065">Although different addictive substance has distinct chemical structures and elicit different pharmacological effects, they may share common neural and molecular pathways. Searching for such common mechanisms could provide insights into the development of generalized treatment for drug addiction <xref rid="b0045" ref-type="bibr">[9]</xref>. This is especially important since persons with substance use disorder frequently take more than one kind of drug concurrently. Alcohol abuse is especially co-morbid with the abuse of many other drugs <xref rid="b0050" ref-type="bibr">[10]</xref>. Thus, the discovery of common mechanisms will benefit drug abusers who take multiple addictive substances. Based on our curated data including addicts take one or more than one kind of drug samples, we found that a few DEGs occur frequently among data relating to chronic abuse, acute abuse, or drug withdrawal. These common genes included the ones that have been studied well in drug addiction such as immediate-early genes (<italic>FOS, ARC, JUN, FOSB, EGR1, EGR2</italic>) <xref rid="b0055" ref-type="bibr">[11]</xref>, <xref rid="b0060" ref-type="bibr">[12]</xref>, <xref rid="b0065" ref-type="bibr">[13]</xref>, <xref rid="b0070" ref-type="bibr">[14]</xref>, <xref rid="b0075" ref-type="bibr">[15]</xref>, <xref rid="b0080" ref-type="bibr">[16]</xref>, <italic>CARTPT</italic>
<xref rid="b0085" ref-type="bibr">[17]</xref>, <xref rid="b0090" ref-type="bibr">[18]</xref>, <xref rid="b0095" ref-type="bibr">[19]</xref>, <xref rid="b0100" ref-type="bibr">[20]</xref>, <italic>PDYN</italic>
<xref rid="b0105" ref-type="bibr">[21]</xref>, <xref rid="b0110" ref-type="bibr">[22]</xref>, <xref rid="b0115" ref-type="bibr">[23]</xref>, <italic>TH</italic>
<xref rid="b0120" ref-type="bibr">[24]</xref>, <xref rid="b0125" ref-type="bibr">[25]</xref>, <xref rid="b0130" ref-type="bibr">[26]</xref>, <xref rid="b0135" ref-type="bibr">[27]</xref>, <xref rid="b0140" ref-type="bibr">[28]</xref>, <italic>BDNF</italic>
<xref rid="b0145" ref-type="bibr">[29]</xref>, <xref rid="b0150" ref-type="bibr">[30]</xref>, <xref rid="b0155" ref-type="bibr">[31]</xref>, <xref rid="b0160" ref-type="bibr">[32]</xref>, <xref rid="b0165" ref-type="bibr">[33]</xref>, <xref rid="b0170" ref-type="bibr">[34]</xref> and <italic>NPY</italic>
<xref rid="b0175" ref-type="bibr">[35]</xref>, <xref rid="b0180" ref-type="bibr">[36]</xref>, <xref rid="b0185" ref-type="bibr">[37]</xref>, <xref rid="b0190" ref-type="bibr">[38]</xref>, <xref rid="b0195" ref-type="bibr">[39]</xref>. Among these common genes, <italic>CARTPT</italic> is the most noteworthy since it expresses differentially upon the chronic abuse of nicotine, morphine, alcohol, methamphetamine, heroin, or cocaine. GWAS result revealed the significant contribution of <italic>CARTPT</italic> to suicide attempts in bipolar disorder (<xref rid="f0015" ref-type="fig">Fig. 3</xref>D) <xref rid="b0200" ref-type="bibr">[40]</xref>, and amphetamine was reported to be an agonist of <italic>CARTPT</italic> retrieved from the drug-gene interaction of DGIdb (<xref rid="f0015" ref-type="fig">Fig. 3</xref>E) <xref rid="b0205" ref-type="bibr">[41]</xref>. Histone H3K4me3 modification activities, a defining mark of gene activation <xref rid="b0210" ref-type="bibr">[42]</xref>, <xref rid="b0215" ref-type="bibr">[43]</xref>, were observed around <italic>CARTPT</italic> during embryonic development process, which provides a potential epigenetic regulator involved in the alteration of specific gene during the development of addiction. In addition, the differential expression of <italic>PDYN</italic>, <italic>TH</italic>, <italic>BDNF</italic>, <italic>and NTRK2</italic> was induced by chronic abuse of five different kinds of drugs. Also, the differential expression of <italic>FOS, EGR1, EGR2, NPY</italic> and <italic>CREB</italic> was induced by withdrawal of three different kinds of substance. The differential expression of <italic>FOS, EGR2, EGR4, SGK1, PLIN4, ARROC2</italic> and <italic>CDKN1A</italic> was induced by acute treatment of three or four different kinds of substance. Numerous genetic evidences showed <italic>DRD2</italic> and <italic>COMT,</italic> another two common gene we identified, were associated with various additive substances <xref rid="b0220" ref-type="bibr">[44]</xref>, <xref rid="b0225" ref-type="bibr">[45]</xref>, <xref rid="b0230" ref-type="bibr">[46]</xref>, <xref rid="b0235" ref-type="bibr">[47]</xref>, <xref rid="b0240" ref-type="bibr">[48]</xref>, <xref rid="b0245" ref-type="bibr">[49]</xref>, <xref rid="b0250" ref-type="bibr">[50]</xref>. However, the underlying mechanisms have not been studied well. Furthermore, although gene expression changes may depend on the length of exposure or withdrawal from the addictive substances <xref rid="b0255" ref-type="bibr">[51]</xref>, we found that a few genes including <italic>FOS</italic>, <italic>ARC</italic>, <italic>EGR1</italic> and <italic>FOSB</italic> differentially expressed irrespective of the stages of addiction. Thus, these common genes might underlie a unitary basis for neurobiological dysfunction of addiction.</p>
    </sec>
    <sec id="s0055">
      <label>3.3</label>
      <title>Future plan</title>
      <p id="p0070">We will continuously update and improve AddictGene in the next few years. DEG and histone modification data will be increased items by searching from PubMed every year. Other data will be extended when the public database we used is updated. In addition, to better understand the linkage between addiction and other psychiatric disorders, we will collect more information including gene expression, epigenetic regulation data of depression, bipolar disorder, and schizophrenia. This will allow AddictGene as a hub for the users to integrate the genes.</p>
    </sec>
  </sec>
  <sec id="s0060">
    <label>4</label>
    <title>Discussion</title>
    <p id="p0075">In the past few years, ERGR provided gene information for scientists to understand pathogenesis of drug addiction. Differentially expressed genes and the associated pathways are important to know their molecular mechanism and function linked to the physiological and behavioral changes. AddictGene we developed offered genetic and transcriptomic functional information on addiction-related DEGs. Users can also discover potential druggability targets to the genes of interest and observe their normal expression profiles in primary tissues. Considering the co-morbidity between addiction and other psychiatric disorders / neurodegenerative disease, multiple psychiatric disorders / neurodegenerative disease-related GWAS and transcriptomic data were also integrated into AddictGene. To further provide insight into the potential epigenetic regulators involved in the expression of specific DEGs, we integrated epigenomic regulatory information including histone modifications and DNA methylation into our current database.</p>
    <p id="p0080">It was proposed that different drugs of abuse share similar addictive actions and rewarding <xref rid="b0265" ref-type="bibr">[52]</xref>. In current study, common pathways of Substance dependence pathways and Nervous system pathways and common differentially expressed genes of <italic>FOS</italic>, <italic>ARC</italic>, <italic>EGR1</italic> and <italic>FOSB</italic> shared by multiple drugs were identified irrespective of the stages of addiction. <italic>FOS</italic>, <italic>FOSB</italic> and <italic>ARC</italic> are all located in Amphetamine addiction pathway. Thereinto, <italic>FOSB</italic> was reported to initiate a multitude of molecular pathways via the formation of AP-1 complexes by interaction with <italic>JUN</italic> and <italic>FOS</italic> gene <xref rid="b0270" ref-type="bibr">[53]</xref>. But molecular roles of <italic>FOSB</italic> of the functional purpose acting on DNA and histones is still unclear. Elucidation of mechanisms of common genes and associated molecular pathways underlying shared rewarding and addictive actions may help the development of effective treatments for a wide range of addictive disorders, especially persons with substance use disorder take more than one kind of drug concurrently.</p>
    <p id="p0085">As a useful repository, AddictGene will help researchers to study the molecular mechanisms underlying addiction, and provide valuable insights into potential therapies for drug harmful use and relapse.</p>
  </sec>
  <sec id="s0065">
    <label>5</label>
    <title>Authors’ contributions</title>
    <p id="p0090">SLS and WY carried out database construction, and data integration and analyses; LC collected and curated data; ZKL provided the conception and design of the study; DQS revised article critically for important intellectual content; ZM designed study, interpreted data and drafted the article. All authors read and approved the final manuscript.</p>
  </sec>
  <sec id="s0001">
    <title>CRediT authorship contribution statement</title>
    <p id="p0001"><bold>Leisheng Shi:</bold> Data curation, Visualization. <bold>Yan Wang:</bold> Funding acquisition, Writing - original draft, Writing - review &amp; editing. <bold>Chong Li:</bold> Formal analysis, Investigation. <bold>Kunlin Zhang:</bold> Formal analysis, Methodology. <bold>Quansheng Du:</bold> Supervision. <bold>Mei Zhao:</bold> Conceptualization, Supervision, Writing - original draft, Funding acquisition.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Declaration of Competing Interest</title>
    <p id="p0100">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>
  </sec>
</body>
<back>
  <ref-list id="bi005">
    <title>References</title>
    <ref id="b0005">
      <label>1</label>
      <element-citation publication-type="journal" id="h0005">
        <person-group person-group-type="author">
          <name>
            <surname>Pol Bodetto</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Carouge</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Fonteneau</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Dietrich</surname>
            <given-names>J.B.</given-names>
          </name>
          <name>
            <surname>Zwiller</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Cocaine represses protein phosphatase-1Cbeta through DNA methylation and Methyl-CpG Binding Protein-2 recruitment in adult rat brain</article-title>
        <source>Neuropharmacology</source>
        <volume>73</volume>
        <year>2013</year>
        <fpage>31</fpage>
        <lpage>40</lpage>
        <pub-id pub-id-type="pmid">23688924</pub-id>
      </element-citation>
    </ref>
    <ref id="b0010">
      <label>2</label>
      <element-citation publication-type="journal" id="h0010">
        <person-group person-group-type="author">
          <name>
            <surname>Chao</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Nestler</surname>
            <given-names>E.J.</given-names>
          </name>
        </person-group>
        <article-title>Molecular neurobiology of drug addiction</article-title>
        <source>Annu Rev Med</source>
        <volume>55</volume>
        <year>2004</year>
        <fpage>113</fpage>
        <lpage>132</lpage>
        <pub-id pub-id-type="pmid">14746512</pub-id>
      </element-citation>
    </ref>
    <ref id="b0015">
      <label>3</label>
      <element-citation publication-type="journal" id="h0015">
        <person-group person-group-type="author">
          <name>
            <surname>Hyman</surname>
            <given-names>S.E.</given-names>
          </name>
          <name>
            <surname>Malenka</surname>
            <given-names>R.C.</given-names>
          </name>
          <name>
            <surname>Nestler</surname>
            <given-names>E.J.</given-names>
          </name>
        </person-group>
        <article-title>Neural mechanisms of addiction: the role of reward-related learning and memory</article-title>
        <source>Annu Rev Neurosci</source>
        <volume>29</volume>
        <year>2006</year>
        <fpage>565</fpage>
        <lpage>598</lpage>
        <pub-id pub-id-type="pmid">16776597</pub-id>
      </element-citation>
    </ref>
    <ref id="b0020">
      <label>4</label>
      <element-citation publication-type="journal" id="h0020">
        <person-group person-group-type="author">
          <name>
            <surname>Nestler</surname>
            <given-names>E.J.</given-names>
          </name>
        </person-group>
        <article-title>Molecular mechanisms of drug addiction</article-title>
        <source>Neuropharmacology</source>
        <volume>47</volume>
        <issue>Suppl 1</issue>
        <year>2004</year>
        <fpage>24</fpage>
        <lpage>32</lpage>
        <pub-id pub-id-type="pmid">15464123</pub-id>
      </element-citation>
    </ref>
    <ref id="b0025">
      <label>5</label>
      <element-citation publication-type="journal" id="h0025">
        <person-group person-group-type="author">
          <name>
            <surname>Rhodes</surname>
            <given-names>J.S.</given-names>
          </name>
          <name>
            <surname>Crabbe</surname>
            <given-names>J.C.</given-names>
          </name>
        </person-group>
        <article-title>Gene expression induced by drugs of abuse</article-title>
        <source>Curr Opin Pharmacol</source>
        <volume>5</volume>
        <year>2005</year>
        <fpage>26</fpage>
        <lpage>33</lpage>
        <pub-id pub-id-type="pmid">15661622</pub-id>
      </element-citation>
    </ref>
    <ref id="b0030">
      <label>6</label>
      <element-citation publication-type="journal" id="h0030">
        <person-group person-group-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>A.Y.</given-names>
          </name>
          <name>
            <surname>Webb</surname>
            <given-names>B.T.</given-names>
          </name>
          <name>
            <surname>Miles</surname>
            <given-names>M.F.</given-names>
          </name>
          <name>
            <surname>Zimmerman</surname>
            <given-names>M.P.</given-names>
          </name>
          <name>
            <surname>Kendler</surname>
            <given-names>K.S.</given-names>
          </name>
        </person-group>
        <article-title>ERGR: An ethanol-related gene resource</article-title>
        <source>Nucleic Acids Res</source>
        <volume>37</volume>
        <year>2009</year>
        <fpage>D840</fpage>
        <lpage>845</lpage>
        <pub-id pub-id-type="pmid">18978021</pub-id>
      </element-citation>
    </ref>
    <ref id="b0035">
      <label>7</label>
      <element-citation publication-type="journal" id="h0035">
        <person-group person-group-type="author">
          <name>
            <surname>Chiang</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Layer</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Faust</surname>
            <given-names>G.G.</given-names>
          </name>
          <name>
            <surname>Lindberg</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Rose</surname>
            <given-names>D.B.</given-names>
          </name>
        </person-group>
        <article-title>SpeedSeq: ultra-fast personal genome analysis and interpretation</article-title>
        <source>Nat Methods</source>
        <volume>12</volume>
        <year>2015</year>
        <fpage>966</fpage>
        <lpage>968</lpage>
        <pub-id pub-id-type="pmid">26258291</pub-id>
      </element-citation>
    </ref>
    <ref id="b0040">
      <label>8</label>
      <element-citation publication-type="journal" id="h0040">
        <person-group person-group-type="author">
          <name>
            <surname>Ramirez</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Dundar</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Diehl</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Gruning</surname>
            <given-names>B.A.</given-names>
          </name>
          <name>
            <surname>Manke</surname>
            <given-names>T.</given-names>
          </name>
        </person-group>
        <article-title>deepTools: a flexible platform for exploring deep-sequencing data</article-title>
        <source>Nucleic Acids Res</source>
        <volume>42</volume>
        <year>2014</year>
        <fpage>W187</fpage>
        <lpage>191</lpage>
        <pub-id pub-id-type="pmid">24799436</pub-id>
      </element-citation>
    </ref>
    <ref id="b0045">
      <label>9</label>
      <element-citation publication-type="journal" id="h0045">
        <person-group person-group-type="author">
          <name>
            <surname>Nestler</surname>
            <given-names>E.J.</given-names>
          </name>
        </person-group>
        <article-title>&lt;Is there a common molecular pathway for addiction.pdf&gt;</article-title>
        <source>Nat Neurosci</source>
        <volume>8</volume>
        <year>2005</year>
        <fpage>5</fpage>
        <pub-id pub-id-type="pmid">15622408</pub-id>
      </element-citation>
    </ref>
    <ref id="b0050">
      <label>10</label>
      <element-citation publication-type="journal" id="h0050">
        <person-group person-group-type="author">
          <name>
            <surname>Arias</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Kranzler</surname>
            <given-names>H.R.</given-names>
          </name>
        </person-group>
        <article-title>Treatment of co-occurring alcohol and other drug use disorders</article-title>
        <source>Alcohol Res Health</source>
        <volume>31</volume>
        <year>2008</year>
        <fpage>155</fpage>
        <lpage>167</lpage>
        <pub-id pub-id-type="pmid">23584817</pub-id>
      </element-citation>
    </ref>
    <ref id="b0055">
      <label>11</label>
      <element-citation publication-type="journal" id="h0055">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>M.C.</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>S.H.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C.H.</given-names>
          </name>
        </person-group>
        <article-title>Chronic methamphetamine treatment reduces the expression of synaptic plasticity genes and changes their DNA methylation status in the mouse brain</article-title>
        <source>Brain Res</source>
        <volume>1629</volume>
        <year>2015</year>
        <fpage>126</fpage>
        <lpage>134</lpage>
        <pub-id pub-id-type="pmid">26496011</pub-id>
      </element-citation>
    </ref>
    <ref id="b0060">
      <label>12</label>
      <element-citation publication-type="journal" id="h0060">
        <person-group person-group-type="author">
          <name>
            <surname>Schochet</surname>
            <given-names>T.L.</given-names>
          </name>
          <name>
            <surname>Kelley</surname>
            <given-names>A.E.</given-names>
          </name>
          <name>
            <surname>Landry</surname>
            <given-names>C.F.</given-names>
          </name>
        </person-group>
        <article-title>Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain</article-title>
        <source>Neuroscience</source>
        <volume>135</volume>
        <year>2005</year>
        <fpage>285</fpage>
        <lpage>297</lpage>
        <pub-id pub-id-type="pmid">16084664</pub-id>
      </element-citation>
    </ref>
    <ref id="b0065">
      <label>13</label>
      <element-citation publication-type="journal" id="h0065">
        <person-group person-group-type="author">
          <name>
            <surname>Lv</surname>
            <given-names>X.F.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L.L.</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>C.L.</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>J.S.</given-names>
          </name>
        </person-group>
        <article-title>NAc Shell Arc/Arg3.1 Protein Mediates Reconsolidation of Morphine CPP by Increased GluR1 Cell Surface Expression: Activation of ERK-Coupled CREB is Required</article-title>
        <source>Int J Neuropsychopharmacol</source>
        <volume>18</volume>
        <year>2015</year>
      </element-citation>
    </ref>
    <ref id="b0070">
      <label>14</label>
      <element-citation publication-type="journal" id="h0070">
        <person-group person-group-type="author">
          <name>
            <surname>Ziolkowska</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Korostynski</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Piechota</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Kubik</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Przewlocki</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>Effects of morphine on immediate-early gene expression in the striatum of C57BL/6J and DBA/2J mice</article-title>
        <source>Pharmacol Rep</source>
        <volume>64</volume>
        <year>2012</year>
        <fpage>1091</fpage>
        <lpage>1104</lpage>
        <pub-id pub-id-type="pmid">23238466</pub-id>
      </element-citation>
    </ref>
    <ref id="b0075">
      <label>15</label>
      <element-citation publication-type="journal" id="h0075">
        <person-group person-group-type="author">
          <name>
            <surname>Ziolkowska</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Kielbinski</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Gieryk</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Soria</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Maldonado</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>Regulation of the immediate-early genes arc and zif268 in a mouse operant model of cocaine seeking reinstatement</article-title>
        <source>J Neural Transm (Vienna)</source>
        <volume>118</volume>
        <year>2011</year>
        <fpage>877</fpage>
        <lpage>887</lpage>
        <pub-id pub-id-type="pmid">21318636</pub-id>
      </element-citation>
    </ref>
    <ref id="b0080">
      <label>16</label>
      <element-citation publication-type="journal" id="h0080">
        <person-group person-group-type="author">
          <name>
            <surname>Samaha</surname>
            <given-names>A.N.</given-names>
          </name>
          <name>
            <surname>Mallet</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Ferguson</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Gonon</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>T.E.</given-names>
          </name>
        </person-group>
        <article-title>The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction</article-title>
        <source>J Neurosci</source>
        <volume>24</volume>
        <year>2004</year>
        <fpage>6362</fpage>
        <lpage>6370</lpage>
        <pub-id pub-id-type="pmid">15254092</pub-id>
      </element-citation>
    </ref>
    <ref id="b0085">
      <label>17</label>
      <element-citation publication-type="journal" id="h0085">
        <person-group person-group-type="author">
          <name>
            <surname>Bakhtazad</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Vousooghi</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Garmabi</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Zarrindast</surname>
            <given-names>M.R.</given-names>
          </name>
        </person-group>
        <article-title>CART peptide and opioid addiction: Expression changes in male rat brain</article-title>
        <source>Neuroscience</source>
        <volume>325</volume>
        <year>2016</year>
        <fpage>63</fpage>
        <lpage>73</lpage>
        <pub-id pub-id-type="pmid">26955782</pub-id>
      </element-citation>
    </ref>
    <ref id="b0090">
      <label>18</label>
      <element-citation publication-type="journal" id="h0090">
        <person-group person-group-type="author">
          <name>
            <surname>Bakhtazad</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Vousooghi</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Garmabi</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Zarrindast</surname>
            <given-names>M.R.</given-names>
          </name>
        </person-group>
        <article-title>Evaluation of the CART peptide expression in morphine sensitization in male rats</article-title>
        <source>Eur J Pharmacol</source>
        <year>2017</year>
      </element-citation>
    </ref>
    <ref id="b0095">
      <label>19</label>
      <element-citation publication-type="journal" id="h0095">
        <person-group person-group-type="author">
          <name>
            <surname>Kuhar</surname>
            <given-names>M.J.</given-names>
          </name>
        </person-group>
        <article-title>CART Peptides and Drugs of Abuse: A Review of Recent Progress</article-title>
        <source>J Drug Alcohol Res</source>
        <volume>5</volume>
        <year>2016</year>
      </element-citation>
    </ref>
    <ref id="b0100">
      <label>20</label>
      <element-citation publication-type="journal" id="h0100">
        <person-group person-group-type="author">
          <name>
            <surname>Bakhtazad</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Vousooghi</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Garmabi</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Zarrindast</surname>
            <given-names>M.R.</given-names>
          </name>
        </person-group>
        <article-title>Evaluation of CART peptide level in rat plasma and CSF: Possible role as a biomarker in opioid addiction</article-title>
        <source>Peptides</source>
        <volume>84</volume>
        <year>2016</year>
        <fpage>1</fpage>
        <lpage>6</lpage>
        <pub-id pub-id-type="pmid">27349817</pub-id>
      </element-citation>
    </ref>
    <ref id="b0105">
      <label>21</label>
      <element-citation publication-type="journal" id="h0105">
        <person-group person-group-type="author">
          <name>
            <surname>Faisal</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Waseem</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Ismatullah</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Taqi</surname>
            <given-names>M.M.</given-names>
          </name>
        </person-group>
        <article-title>A molecular prospective provides new insights into implication of PDYN and OPRK1 genes in alcohol dependence</article-title>
        <source>Comput Biol Med</source>
        <volume>53</volume>
        <year>2014</year>
        <fpage>250</fpage>
        <lpage>257</lpage>
        <pub-id pub-id-type="pmid">25177835</pub-id>
      </element-citation>
    </ref>
    <ref id="b0110">
      <label>22</label>
      <element-citation publication-type="journal" id="h0110">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>K.W.</given-names>
          </name>
        </person-group>
        <article-title>A New Insight into the Role of CART in Cocaine Reward: Involvement of CaMKII and Inhibitory G-Protein Coupled Receptor Signaling</article-title>
        <source>Front Cell Neurosci</source>
        <volume>11</volume>
        <year>2017</year>
        <fpage>244</fpage>
        <pub-id pub-id-type="pmid">28860971</pub-id>
      </element-citation>
    </ref>
    <ref id="b0115">
      <label>23</label>
      <element-citation publication-type="journal" id="h0115">
        <person-group person-group-type="author">
          <name>
            <surname>Butelman</surname>
            <given-names>E.R.</given-names>
          </name>
          <name>
            <surname>Yuferov</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Kreek</surname>
            <given-names>M.J.</given-names>
          </name>
        </person-group>
        <article-title>kappa-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction</article-title>
        <source>Trends Neurosci</source>
        <volume>35</volume>
        <year>2012</year>
        <fpage>587</fpage>
        <lpage>596</lpage>
        <pub-id pub-id-type="pmid">22709632</pub-id>
      </element-citation>
    </ref>
    <ref id="b0120">
      <label>24</label>
      <element-citation publication-type="journal" id="h0120">
        <person-group person-group-type="author">
          <name>
            <surname>Belin</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Deroche-Gamonet</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Jaber</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Cocaine-induced sensitization is associated with altered dynamics of transcriptional responses of the dopamine transporter, tyrosine hydroxylase, and dopamine D2 receptors in C57Bl/6J mice</article-title>
        <source>Psychopharmacology</source>
        <volume>193</volume>
        <year>2007</year>
        <fpage>567</fpage>
        <lpage>578</lpage>
        <pub-id pub-id-type="pmid">17505818</pub-id>
      </element-citation>
    </ref>
    <ref id="b0125">
      <label>25</label>
      <element-citation publication-type="journal" id="h0125">
        <person-group person-group-type="author">
          <name>
            <surname>Garcia-Perez</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Lopez-Bellido</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Hidalgo</surname>
            <given-names>J.M.</given-names>
          </name>
          <name>
            <surname>Rodriguez</surname>
            <given-names>R.E.</given-names>
          </name>
          <name>
            <surname>Laorden</surname>
            <given-names>M.L.</given-names>
          </name>
        </person-group>
        <article-title>Morphine regulates Argonaute 2 and TH expression and activity but not miR-133b in midbrain dopaminergic neurons</article-title>
        <source>Addict Biol</source>
        <volume>20</volume>
        <year>2015</year>
        <fpage>104</fpage>
        <lpage>119</lpage>
        <pub-id pub-id-type="pmid">23927484</pub-id>
      </element-citation>
    </ref>
    <ref id="b0130">
      <label>26</label>
      <element-citation publication-type="journal" id="h0130">
        <person-group person-group-type="author">
          <name>
            <surname>Garcia-Perez</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Lopez-Bellido</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Rodriguez</surname>
            <given-names>R.E.</given-names>
          </name>
          <name>
            <surname>Laorden</surname>
            <given-names>M.L.</given-names>
          </name>
          <name>
            <surname>Nunez</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <article-title>Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal</article-title>
        <source>Brain Struct Funct</source>
        <volume>220</volume>
        <year>2015</year>
        <fpage>1901</fpage>
        <lpage>1919</lpage>
        <pub-id pub-id-type="pmid">24706046</pub-id>
      </element-citation>
    </ref>
    <ref id="b0135">
      <label>27</label>
      <element-citation publication-type="journal" id="h0135">
        <person-group person-group-type="author">
          <name>
            <surname>Beitner-Johnson</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Nestler</surname>
            <given-names>E.J.</given-names>
          </name>
        </person-group>
        <article-title>Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions</article-title>
        <source>J Neurochem</source>
        <volume>57</volume>
        <year>1991</year>
        <fpage>344</fpage>
        <lpage>347</lpage>
        <pub-id pub-id-type="pmid">1675665</pub-id>
      </element-citation>
    </ref>
    <ref id="b0140">
      <label>28</label>
      <element-citation publication-type="journal" id="h0140">
        <person-group person-group-type="author">
          <name>
            <surname>Renard</surname>
            <given-names>G.M.</given-names>
          </name>
          <name>
            <surname>Sotomayor-Zarate</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Blanco</surname>
            <given-names>E.H.</given-names>
          </name>
          <name>
            <surname>Gysling</surname>
            <given-names>K.</given-names>
          </name>
        </person-group>
        <article-title>Withdrawal from chronic amphetamine reduces dopamine transmission in the rat lateral septum</article-title>
        <source>J Neurosci Res</source>
        <volume>92</volume>
        <year>2014</year>
        <fpage>937</fpage>
        <lpage>943</lpage>
        <pub-id pub-id-type="pmid">24753218</pub-id>
      </element-citation>
    </ref>
    <ref id="b0145">
      <label>29</label>
      <element-citation publication-type="journal" id="h0145">
        <person-group person-group-type="author">
          <name>
            <surname>Bobadilla</surname>
            <given-names>A.C.</given-names>
          </name>
          <name>
            <surname>Garcia-Keller</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Chareunsouk</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Hyde</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Camacho</surname>
            <given-names>D.M.</given-names>
          </name>
        </person-group>
        <article-title>Accumbens brain-derived neurotrophic factor (BDNF) transmission inhibits cocaine seeking</article-title>
        <source>Addict Biol</source>
        <year>2018</year>
      </element-citation>
    </ref>
    <ref id="b0150">
      <label>30</label>
      <element-citation publication-type="journal" id="h0150">
        <person-group person-group-type="author">
          <name>
            <surname>Anderson</surname>
            <given-names>E.M.</given-names>
          </name>
          <name>
            <surname>Wissman</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Chemplanikal</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Buzin</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Guzman</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>BDNF-TrkB controls cocaine-induced dendritic spines in rodent nucleus accumbens dissociated from increases in addictive behaviors</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <volume>114</volume>
        <year>2017</year>
        <fpage>9469</fpage>
        <lpage>9474</lpage>
        <pub-id pub-id-type="pmid">28808012</pub-id>
      </element-citation>
    </ref>
    <ref id="b0155">
      <label>31</label>
      <element-citation publication-type="journal" id="h0155">
        <person-group person-group-type="author">
          <name>
            <surname>Corominas-Roso</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Roncero</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Eiroa-Orosa</surname>
            <given-names>F.J.</given-names>
          </name>
          <name>
            <surname>Gonzalvo</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Grau-Lopez</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence</article-title>
        <source>Eur Neuropsychopharmacol</source>
        <volume>23</volume>
        <year>2013</year>
        <fpage>1078</fpage>
        <lpage>1084</lpage>
        <pub-id pub-id-type="pmid">23021567</pub-id>
      </element-citation>
    </ref>
    <ref id="b0160">
      <label>32</label>
      <element-citation publication-type="journal" id="h0160">
        <person-group person-group-type="author">
          <name>
            <surname>Ting</surname>
            <given-names>A.K.R.</given-names>
          </name>
          <name>
            <surname>Vargas-Perez</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Bufalino</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Bahi</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Dreyer</surname>
            <given-names>J.L.</given-names>
          </name>
        </person-group>
        <article-title>Infusion of brain-derived neurotrophic factor into the ventral tegmental area switches the substrates mediating ethanol motivation</article-title>
        <source>Eur J Neurosci</source>
        <volume>37</volume>
        <year>2013</year>
        <fpage>996</fpage>
        <lpage>1003</lpage>
        <pub-id pub-id-type="pmid">23279128</pub-id>
      </element-citation>
    </ref>
    <ref id="b0165">
      <label>33</label>
      <element-citation publication-type="journal" id="h0165">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Wolf</surname>
            <given-names>M.E.</given-names>
          </name>
        </person-group>
        <article-title>Multiple faces of BDNF in cocaine addiction</article-title>
        <source>Behav Brain Res</source>
        <volume>279</volume>
        <year>2015</year>
        <fpage>240</fpage>
        <lpage>254</lpage>
        <pub-id pub-id-type="pmid">25449839</pub-id>
      </element-citation>
    </ref>
    <ref id="b0170">
      <label>34</label>
      <element-citation publication-type="journal" id="h0170">
        <person-group person-group-type="author">
          <name>
            <surname>Hearing</surname>
            <given-names>M.C.</given-names>
          </name>
          <name>
            <surname>See</surname>
            <given-names>R.E.</given-names>
          </name>
          <name>
            <surname>McGinty</surname>
            <given-names>J.F.</given-names>
          </name>
        </person-group>
        <article-title>Relapse to cocaine-seeking increases activity-regulated gene expression differentially in the striatum and cerebral cortex of rats following short or long periods of abstinence</article-title>
        <source>Brain Struct Funct</source>
        <volume>213</volume>
        <year>2008</year>
        <fpage>215</fpage>
        <lpage>227</lpage>
        <pub-id pub-id-type="pmid">18488248</pub-id>
      </element-citation>
    </ref>
    <ref id="b0175">
      <label>35</label>
      <element-citation publication-type="journal" id="h0175">
        <person-group person-group-type="author">
          <name>
            <surname>Obuchowicz</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Turchan</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Przewlocki</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Herman</surname>
            <given-names>Z.S.</given-names>
          </name>
        </person-group>
        <article-title>Amphetamine-induced effects on neuropeptide Y in the rat brain</article-title>
        <source>Pharmacol Rep</source>
        <volume>57</volume>
        <year>2005</year>
        <fpage>321</fpage>
        <lpage>329</lpage>
        <pub-id pub-id-type="pmid">15985714</pub-id>
      </element-citation>
    </ref>
    <ref id="b0180">
      <label>36</label>
      <element-citation publication-type="journal" id="h0180">
        <person-group person-group-type="author">
          <name>
            <surname>Okahisa</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Ujike</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Kotaka</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Morita</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Kodama</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence</article-title>
        <source>Psychiatry Clin Neurosci</source>
        <volume>63</volume>
        <year>2009</year>
        <fpage>417</fpage>
        <lpage>422</lpage>
        <pub-id pub-id-type="pmid">19566775</pub-id>
      </element-citation>
    </ref>
    <ref id="b0185">
      <label>37</label>
      <element-citation publication-type="journal" id="h0185">
        <person-group person-group-type="author">
          <name>
            <surname>Pleil</surname>
            <given-names>K.E.</given-names>
          </name>
          <name>
            <surname>Rinker</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Lowery-Gionta</surname>
            <given-names>E.G.</given-names>
          </name>
          <name>
            <surname>Mazzone</surname>
            <given-names>C.M.</given-names>
          </name>
          <name>
            <surname>McCall</surname>
            <given-names>N.M.</given-names>
          </name>
        </person-group>
        <source>NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking.</source>
        <volume>18</volume>
        <year>2015</year>
        <fpage>545</fpage>
        <lpage>552</lpage>
      </element-citation>
    </ref>
    <ref id="b0190">
      <label>38</label>
      <element-citation publication-type="journal" id="h0190">
        <person-group person-group-type="author">
          <name>
            <surname>Robinson</surname>
            <given-names>S.L.</given-names>
          </name>
          <name>
            <surname>Thiele</surname>
            <given-names>T.E.</given-names>
          </name>
        </person-group>
        <article-title>The Role of Neuropeptide Y (NPY) in Alcohol and Drug Abuse Disorders</article-title>
        <source>Int Rev Neurobiol</source>
        <volume>136</volume>
        <year>2017</year>
        <fpage>177</fpage>
        <lpage>197</lpage>
        <pub-id pub-id-type="pmid">29056151</pub-id>
      </element-citation>
    </ref>
    <ref id="b0195">
      <label>39</label>
      <element-citation publication-type="journal" id="h0195">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Hauger</surname>
            <given-names>R.L.</given-names>
          </name>
          <name>
            <surname>Goldman</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Genetic modulation of plasma NPY stress response is suppressed in substance abuse: association with clinical outcomes</article-title>
        <source>Nat Neurosci</source>
        <volume>37</volume>
        <year>2012</year>
        <fpage>554</fpage>
        <lpage>564</lpage>
      </element-citation>
    </ref>
    <ref id="b0200">
      <label>40</label>
      <element-citation publication-type="journal" id="h0200">
        <person-group person-group-type="author">
          <name>
            <surname>Willour</surname>
            <given-names>V.L.</given-names>
          </name>
          <name>
            <surname>Seifuddin</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Mahon</surname>
            <given-names>P.B.</given-names>
          </name>
          <name>
            <surname>Jancic</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Pirooznia</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>A genome-wide association study of attempted suicide</article-title>
        <source>Mol Psychiatry</source>
        <volume>17</volume>
        <year>2012</year>
        <fpage>433</fpage>
        <lpage>444</lpage>
        <pub-id pub-id-type="pmid">21423239</pub-id>
      </element-citation>
    </ref>
    <ref id="b0205">
      <label>41</label>
      <element-citation publication-type="journal" id="h0205">
        <person-group person-group-type="author">
          <name>
            <surname>Scruggs</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>C.C.</given-names>
          </name>
          <name>
            <surname>Scruggs</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Dun</surname>
            <given-names>N.J.</given-names>
          </name>
        </person-group>
        <article-title>Cocaine- and amphetamine-regulated transcript peptide potentiates spinal glutamatergic sympathoexcitation in anesthetized rats</article-title>
        <source>Regul Pept</source>
        <volume>127</volume>
        <year>2005</year>
        <fpage>79</fpage>
        <lpage>85</lpage>
        <pub-id pub-id-type="pmid">15680473</pub-id>
      </element-citation>
    </ref>
    <ref id="b0210">
      <label>42</label>
      <element-citation publication-type="journal" id="h0210">
        <person-group person-group-type="author">
          <name>
            <surname>Barski</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Cuddapah</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Roh</surname>
            <given-names>T.Y.</given-names>
          </name>
          <name>
            <surname>Schones</surname>
            <given-names>D.E.</given-names>
          </name>
        </person-group>
        <article-title>High-resolution profiling of histone methylations in the human genome</article-title>
        <source>Cell</source>
        <volume>129</volume>
        <year>2007</year>
        <fpage>823</fpage>
        <lpage>837</lpage>
        <pub-id pub-id-type="pmid">17512414</pub-id>
      </element-citation>
    </ref>
    <ref id="b0215">
      <label>43</label>
      <element-citation publication-type="journal" id="h0215">
        <person-group person-group-type="author">
          <name>
            <surname>Lauberth</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Nakayama</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Ferris</surname>
            <given-names>A.L.</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>Z.</given-names>
          </name>
        </person-group>
        <article-title>H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation</article-title>
        <source>Cell</source>
        <volume>152</volume>
        <year>2013</year>
        <fpage>1021</fpage>
        <lpage>1036</lpage>
        <pub-id pub-id-type="pmid">23452851</pub-id>
      </element-citation>
    </ref>
    <ref id="b0220">
      <label>44</label>
      <element-citation publication-type="journal" id="h0220">
        <person-group person-group-type="author">
          <name>
            <surname>Batalla</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Soriano-Mas</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Lopez-Sola</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Torrens</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Crippa</surname>
            <given-names>J.A.</given-names>
          </name>
        </person-group>
        <article-title>Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users</article-title>
        <source>Addict Biol</source>
        <volume>19</volume>
        <year>2014</year>
        <fpage>722</fpage>
        <lpage>732</lpage>
        <pub-id pub-id-type="pmid">23311613</pub-id>
      </element-citation>
    </ref>
    <ref id="b0225">
      <label>45</label>
      <element-citation publication-type="journal" id="h0225">
        <person-group person-group-type="author">
          <name>
            <surname>Buhler</surname>
            <given-names>K.M.</given-names>
          </name>
          <name>
            <surname>Gine</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Echeverry-Alzate</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Calleja-Conde</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>de Fonseca</surname>
            <given-names>F.R.</given-names>
          </name>
        </person-group>
        <article-title>Common single nucleotide variants underlying drug addiction: more than a decade of research</article-title>
        <source>Addict Biol</source>
        <volume>20</volume>
        <year>2015</year>
        <fpage>845</fpage>
        <lpage>871</lpage>
        <pub-id pub-id-type="pmid">25603899</pub-id>
      </element-citation>
    </ref>
    <ref id="b0230">
      <label>46</label>
      <element-citation publication-type="journal" id="h0230">
        <person-group person-group-type="author">
          <name>
            <surname>De Ruyck</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Nackaerts</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Beels</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Werbrouck</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>De Volder</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients</article-title>
        <source>Pharmacogenomics</source>
        <volume>11</volume>
        <year>2010</year>
        <fpage>1053</fpage>
        <lpage>1063</lpage>
        <pub-id pub-id-type="pmid">20712524</pub-id>
      </element-citation>
    </ref>
    <ref id="b0235">
      <label>47</label>
      <element-citation publication-type="journal" id="h0235">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Lang</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Reece</surname>
            <given-names>A.S.</given-names>
          </name>
        </person-group>
        <article-title>Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese</article-title>
        <source>Hum Psychopharmacol</source>
        <volume>21</volume>
        <year>2017</year>
        <fpage>404</fpage>
        <lpage>412</lpage>
      </element-citation>
    </ref>
    <ref id="b0240">
      <label>48</label>
      <element-citation publication-type="journal" id="h0240">
        <person-group person-group-type="author">
          <name>
            <surname>Horowitz</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Kotler</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Shufman</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Aharoni</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Kremer</surname>
            <given-names>I.</given-names>
          </name>
        </person-group>
        <article-title>Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study</article-title>
        <source>Am J Med Genet</source>
        <volume>96</volume>
        <year>2000</year>
        <fpage>599</fpage>
        <lpage>603</lpage>
        <pub-id pub-id-type="pmid">11054766</pub-id>
      </element-citation>
    </ref>
    <ref id="b0245">
      <label>49</label>
      <element-citation publication-type="journal" id="h0245">
        <person-group person-group-type="author">
          <name>
            <surname>Lohoff</surname>
            <given-names>F.W.</given-names>
          </name>
          <name>
            <surname>Weller</surname>
            <given-names>A.E.</given-names>
          </name>
          <name>
            <surname>Bloch</surname>
            <given-names>P.J.</given-names>
          </name>
          <name>
            <surname>Nall</surname>
            <given-names>A.H.</given-names>
          </name>
          <name>
            <surname>Ferraro</surname>
            <given-names>T.N.</given-names>
          </name>
        </person-group>
        <article-title>Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence</article-title>
        <source>Neuropsychopharmacology</source>
        <volume>33</volume>
        <year>2008</year>
        <fpage>3078</fpage>
        <lpage>3084</lpage>
        <pub-id pub-id-type="pmid">18704099</pub-id>
      </element-citation>
    </ref>
    <ref id="b0250">
      <label>50</label>
      <element-citation publication-type="journal" id="h0250">
        <person-group person-group-type="author">
          <name>
            <surname>Malecka</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Jasiewicz</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Suchanecka</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Samochowiec</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Grzywacz</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Association and family studies of DRD2 gene polymorphisms in alcohol dependence syndrome</article-title>
        <source>Postepy Hig Med Dosw (Online)</source>
        <volume>68</volume>
        <year>2014</year>
        <fpage>1257</fpage>
        <lpage>1263</lpage>
        <pub-id pub-id-type="pmid">25380208</pub-id>
      </element-citation>
    </ref>
    <ref id="b0255">
      <label>51</label>
      <element-citation publication-type="journal" id="h0255">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Enoch</surname>
            <given-names>M.A.</given-names>
          </name>
          <name>
            <surname>Goldman</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Gene expression in the addicted brain</article-title>
        <source>Int Rev Neurobiol</source>
        <volume>116</volume>
        <year>2014</year>
        <fpage>251</fpage>
        <lpage>273</lpage>
        <pub-id pub-id-type="pmid">25172478</pub-id>
      </element-citation>
    </ref>
    <ref id="b0265">
      <label>52</label>
      <element-citation publication-type="journal" id="h0265">
        <person-group person-group-type="author">
          <name>
            <surname>Nestler</surname>
            <given-names>E.J.</given-names>
          </name>
        </person-group>
        <article-title>Is there a common molecular pathway for addiction?</article-title>
        <source>Nat Neurosci</source>
        <volume>8</volume>
        <year>2005</year>
        <fpage>1445</fpage>
        <lpage>1449</lpage>
        <pub-id pub-id-type="pmid">16251986</pub-id>
      </element-citation>
    </ref>
    <ref id="b0270">
      <label>53</label>
      <element-citation publication-type="journal" id="h0270">
        <person-group person-group-type="author">
          <name>
            <surname>Ruffle</surname>
            <given-names>J.K.</given-names>
          </name>
        </person-group>
        <article-title>Molecular neurobiology of addiction: what's all the (Delta)FosB about?</article-title>
        <source>Am J Drug Alcohol Abuse</source>
        <volume>40</volume>
        <year>2014</year>
        <fpage>428</fpage>
        <lpage>437</lpage>
        <pub-id pub-id-type="pmid">25083822</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <sec id="s0080" sec-type="supplementary-material">
    <label>Appendix A</label>
    <title>Supplementary data</title>
    <p id="p0115">The following are the Supplementary data to this article:<supplementary-material content-type="local-data" id="m0010"><caption><title>Supplementary data 1</title></caption><media xlink:href="mmc1.docx"/></supplementary-material></p>
    <p id="p0120">
      <supplementary-material content-type="local-data" id="m0005">
        <caption>
          <title>Supplementary data 2</title>
        </caption>
        <media xlink:href="mmc2.csv"/>
      </supplementary-material>
    </p>
  </sec>
  <ack id="ak005">
    <title>Acknowledgements</title>
    <p id="p0105">This work was supported by the National Natural Science Foundation of China (No. 91132728, 31741062, 61401459); and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences.</p>
  </ack>
  <fn-group>
    <fn id="s0075" fn-type="supplementary-material">
      <label>Appendix A</label>
      <p id="p0110">Supplementary data to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.csbj.2021.04.027" id="ir065">https://doi.org/10.1016/j.csbj.2021.04.027</ext-link>.</p>
    </fn>
  </fn-group>
</back>
